Magenta Therapeutics (MGTA) Short Interest Ratio & Short Volume → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free MGTA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Magenta Therapeutics Short Interest DataCurrent Short Volume383,000 sharesPrevious Short Volume286,000 sharesChange Vs. Previous Month+33.92%Dollar Volume Sold Short$308,315.00Short Interest Ratio / Days to Cover1.2Last Record DateAugust 15, 2023Outstanding Shares60,665,000 sharesFloat Size47,540,000 sharesShort Percent of Float0.81%Today's Trading Volume376,000 sharesAverage Trading Volume848,835 sharesToday's Volume Vs. Average44% Short Selling Magenta Therapeutics ? Sign up to receive the latest short interest report for Magenta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMGTA Short Interest Over TimeMGTA Days to Cover Over TimeMGTA Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Magenta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/2023383,000 shares $308,315.00 +33.9%0.8%1.2 $0.81 7/31/2023286,000 shares $229,372.00 -27.2%0.6%0.8 $0.80 7/15/2023392,700 shares $301,868.49 -30.1%0.8%0.8 $0.77 6/30/2023562,100 shares $426,071.80 +4.9%1.2%1.1 $0.76 6/15/2023535,800 shares $353,628.00 +8.1%1.1%1.1 $0.66 5/31/2023495,600 shares $320,851.44 +21.2%1.0%1 $0.65 Get the Latest News and Ratings for MGTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Magenta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2023408,800 shares $286,160.00 -56.0%0.9%0.8 $0.70 4/30/2023930,000 shares $728,655.00 -12.3%2.1%1.2 $0.78 4/15/20231,060,000 shares $825,740.00 -10.9%2.4%0.7 $0.78 3/31/20231,190,000 shares $945,693.00 -20.7%2.7%0.8 $0.79 3/15/20231,500,000 shares $1.11 million +3.5%3.4%0.8 $0.74 2/28/20231,450,000 shares $1.17 million -5.8%3.2%0.5 $0.81 2/15/20231,540,000 shares $1.29 million +266.0%3.5%0.6 $0.84 1/31/2023420,800 shares $230,135.52 -31.5%1.1%0.2 $0.55 1/15/2023614,100 shares $329,771.70 -35.2%1.6%0.4 $0.54 12/30/2022947,700 shares $374,341.50 -80.8%2.5%0.7 $0.40 12/15/20224,930,000 shares $4.59 million +1,545.5%12.8%4.1 $0.93 11/30/2022299,600 shares $344,540.00 -6.7%0.8%1.5 $1.15 11/15/2022321,200 shares $481,800.00 -21.1%0.8%2 $1.50 10/31/2022407,200 shares $525,288.00 -2.4%1.1%2.6 $1.29 10/15/2022417,200 shares $500,640.00 -12.7%1.1%2.7 $1.20 9/30/2022478,000 shares $673,980.00 +4.2%1.3%2.9 $1.41 9/15/2022458,800 shares $798,312.00 +11.0%1.2%1.9 $1.74 8/31/2022413,500 shares $727,760.00 -14.5%1.1%1.7 $1.76 8/15/2022483,800 shares $856,326.00 -6.4%1.3%2 $1.77 7/31/2022516,900 shares $827,040.00 -11.6%1.4%1.7 $1.60 7/15/2022584,900 shares $1.09 million -32.5%1.6%1.8 $1.86 6/30/2022866,000 shares $1.04 million -50.5%2.4%2.6 $1.20 6/15/20221,750,000 shares $2.10 million +6.1%4.8%5.5 $1.20 5/31/20221,650,000 shares $1.91 million +16.2%4.5%6.1 $1.16 5/15/20221,420,000 shares $1.62 million -2.7%3.9%5.1 $1.14 4/30/20221,460,000 shares $2.09 million +51.7%3.6%6.4 $1.43 4/15/2022962,400 shares $2.16 million -1.8%2.4%3.4 $2.24 3/31/2022980,400 shares $2.84 million -25.7%2.4%3.1 $2.90 3/15/20221,320,000 shares $3.78 million +1.5%3.3%3.9 $2.86 2/28/20221,300,000 shares $4.10 million +33.0%3.2%4 $3.15 2/15/2022977,400 shares $3.12 million +29.6%2.4%3.1 $3.19 1/31/2022754,000 shares $2.47 million -24.5%1.9%2.5 $3.27 1/15/2022998,400 shares $4.47 million -15.4%2.5%3.6 $4.48 12/31/20211,180,000 shares $5.23 million -2.5%2.9%6.6 $4.43the most reliable asset on earth is making a comeback (Ad)Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.And you can see how it works for FREE when you Click Here MGTA Short Interest - Frequently Asked Questions What is Magenta Therapeutics' current short interest? Short interest is the volume of Magenta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 383,000 shares of MGTA short. 0.81% of Magenta Therapeutics' shares are currently sold short. Learn More on Magenta Therapeutics' current short interest. What is a good short interest ratio for Magenta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGTA shares currently have a short interest ratio of 1.0. Learn More on Magenta Therapeutics's short interest ratio. What is a good short interest percentage for Magenta Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Magenta Therapeutics' floating shares are currently sold short. Is Magenta Therapeutics' short interest increasing or decreasing? Magenta Therapeutics saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 383,000 shares, an increase of 33.9% from the previous total of 286,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Magenta Therapeutics' float size? Magenta Therapeutics currently has issued a total of 60,665,000 shares. Some of Magenta Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Magenta Therapeutics currently has a public float of 47,540,000 shares. How does Magenta Therapeutics' short interest compare to its competitors? 0.81% of Magenta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Magenta Therapeutics: Dyadic International, Inc. (0.92%), Cellectar Biosciences, Inc. (16.89%), Gamida Cell Ltd. (10.38%), LianBio (0.36%), Aileron Therapeutics, Inc. (0.83%), Freeline Therapeutics Holdings plc (0.58%), Regulus Therapeutics Inc. (13.02%), Unity Biotechnology, Inc. (1.90%), Leap Therapeutics, Inc. (4.82%), Synlogic, Inc. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.78 billion), Occidental Petroleum Co. ($3.04 billion), Royal Caribbean Cruises Ltd. ($2.10 billion), Celsius Holdings, Inc. ($1.98 billion), Coinbase Global, Inc. ($1.97 billion), T. Rowe Price Group, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.83 billion), Tractor Supply ($1.82 billion), Moderna, Inc. ($1.66 billion), and CarMax, Inc. ($1.49 billion). View all of the most shorted stocks. What does it mean to sell short Magenta Therapeutics stock? Short selling MGTA is an investing strategy that aims to generate trading profit from Magenta Therapeutics as its price is falling. MGTA shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Magenta Therapeutics? A short squeeze for Magenta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGTA, which in turn drives the price of the stock up even further. How often is Magenta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGTA, twice per month. The most recent reporting period available is August, 15 2023. More Short Interest Resources from MarketBeat Related Companies: DYAI Short Squeeze CLRB Short Squeeze GMDA Short Squeeze LIAN Short Squeeze ALRN Short Squeeze FRLN Short Squeeze RGLS Short Squeeze UBX Short Squeeze LPTX Short Squeeze SYBX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGTA) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company